Home / PLAU Knockout Cell Lines

PLAU Knockout Cell Lines

Gene: PLAU

Official Full Name: plasminogen activator, urokinaseprovided by HGNC

Gene Summary: This gene encodes a secreted serine protease that converts plasminogen to plasmin. The encoded preproprotein is proteolytically processed to generate A and B polypeptide chains. These chains associate via a single disulfide bond to form the catalytically inactive high molecular weight urokinase-type plasminogen activator (HMW-uPA). HMW-uPA can be further processed into the catalytically active low molecular weight urokinase-type plasminogen activator (LMW-uPA). This low molecular weight form does not bind to the urokinase-type plasminogen activator receptor. Mutations in this gene may be associated with Quebec platelet disorder and late-onset Alzheimer's disease. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO11020 PLAU Knockout cell line (HeLa) Human PLAU 1:3~1:6 Negative Online Inquiry
KO11021 PLAU Knockout cell line (HCT 116) Human PLAU 1:2~1:4 Negative Online Inquiry
KO11022 PLAU Knockout cell line (A549) Human PLAU 1:3~1:4 Negative Online Inquiry

Background

PLAU Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to silence the expression of the plasminogen activator, urokinase (PLAU) gene. This targeted knockout approach allows researchers to investigate the functional roles of PLAU in various physiological and pathological contexts, providing a critical tool for studying cellular processes such as tissue remodeling, angiogenesis, and cancer metastasis where PLAU is known to play a significant role.

The core mechanism behind these knockout cell lines relies on the CRISPR-Cas9 technology, which enables precise gene editing through the introduction of double-strand breaks in the DNA at targeted loci. This process results in the disruption of PLAU expression, effectively creating a loss-of-function model. Researchers can then evaluate the consequences of PLAU absence on cellular behavior, signaling pathways, and interactions with extracellular matrix components.

From a scientific perspective, PLAU Gene Knockout Cell Lines are invaluable for exploring the underlying mechanisms of diseases like cancer, where PLAU has been implicated in tumor progression and metastasis. Their applications extend beyond fundamental research; they provide insights that are directly relevant to the development of therapeutic strategies and drugs aimed at modulating PLAU activity in clinical settings.

Compared to alternative models, such as transient transfection methods or pharmacological inhibition, PLAU Gene Knockout Cell Lines offer stable, long-term expression alterations and reproducibility, ensuring consistent data across multiple experiments. The targeted nature of the gene knockout minimizes off-target effects common with other genetic modification techniques, thus enhancing experimental reliability.

For researchers and clinicians alike, using PLAU Gene Knockout Cell Lines translates into a powerful opportunity to delve deeper into gene function, disease mechanisms, and potential therapeutic interventions. Furthermore, our company prides itself on its commitment to quality and precision in developing genetic tools. With our expertise and dedication to advancing modern biology, we provide researchers with the reliability needed to push the boundaries of scientific discovery.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.